Paige Prostate Suite
An AI-assisted digital pathology suite from Paige for reviewing prostate biopsy slides. Its applications help pathologists detect suspicious tissue, grade prostate cancer, quantify tumor extent, and support case review.
Why Abandoned
Paige continues to list the Prostate Suite and its component applications on its official website. Current product pages and company materials indicate commercial availability, though availability and regulatory status vary by application and market.
🩺 Health Signals
No checks have been run on this tool yet.
📅 Timeline
Paige.AI launched
Paige Prostate received FDA authorization
Paige Prostate Suite introduced
Microsoft announced Paige collaboration
🔄 Alternatives to Paige Prostate Suite
Bard / Gemini
🟢ActiveGoogle's AI assistant, originally Bard, rebranded to Gemini with multimodal capabilities.
Hugging Face
🟢ActiveThe GitHub of machine learning — hosting models, datasets, and AI applications.
Microsoft Copilot
🟢ActiveMicrosoft Copilot is a generative AI assistant available on the web, Windows, mobile devices, and Microsoft Edge. It answers questions, drafts and summarizes text, creates images, and can connect with Microsoft services.
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
❓ Frequently Asked Questions
What is Paige Prostate Suite?
Paige Prostate Suite is a collection of AI-assisted digital pathology applications for prostate biopsy review. It is designed to help pathologists identify suspicious cancer, grade tumors, quantify tumor extent, and assess related findings.
How does Paige Prostate Suite help diagnose prostate cancer?
The suite analyzes digitized hematoxylin-and-eosin-stained prostate biopsy slides and highlights or measures features relevant to a pathologist's review. It supports clinical interpretation rather than replacing the pathologist's final diagnosis.
Is Paige Prostate Suite FDA approved?
Paige Prostate, a cancer-detection application within Paige's prostate portfolio, received FDA De Novo authorization in September 2021. That authorization should not be assumed to cover every application in the broader suite; regulatory status depends on the specific module and jurisdiction.
Who uses Paige Prostate Suite?
It is intended for pathology laboratories and qualified pathologists working with compatible digital pathology systems. Deployment requirements, supported scanners, and availability can vary by region and product component.
Is Paige Prostate Suite still available?
Yes. Paige's official website continues to present the Prostate Suite and associated prostate pathology products. Because medical-device availability varies by country and intended use, prospective users should verify current local regulatory and commercial status with Paige.